| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |